Soliqua 30 60

Product Overview
Soliqua 30 60 is a combination medication used to treat type 2 diabetes. It contains two active ingredients: insulin glargine and lixisenatide. This product helps control blood sugar levels in adults with diabetes.

Key Benefits
- Dual action of insulin glargine and lixisenatide for effective blood sugar control
- Once-daily injection for convenience
- Helps reduce the risk of cardiovascular events in patients with diabetes
- Easy-to-use pen for precise dosing

How It Works
Insulin glargine works by lowering blood sugar levels by mimicking the effects of natural insulin. Lixisenatide helps regulate blood sugar levels by stimulating insulin production and slowing down the absorption of glucose in the intestines.

Directions for Use
1. Wash your hands before using the Soliqua pen.
2. Choose a clean injection site on your stomach, thigh, or upper arm.
3. Prime the pen by dialing 2 units to remove any air bubbles.
4. Dial the dose prescribed by your healthcare provider.
5. Inject the medication subcutaneously.
6. Dispose of the needle safely after use.

Precautions
- Do not share your Soliqua pen with others.
- Monitor your blood sugar levels regularly as directed by your healthcare provider.
- Inform your doctor about any changes in your diet, exercise, or medications.
- Be cautious when driving or operating machinery as low blood sugar levels can affect your ability to concentrate.

Storage Instructions
Store the Soliqua pen in the refrigerator between 36°F to 46°F (2°C to 8°C). Do not freeze. Once in use, the pen can be kept at room temperature not exceeding 86°F (30°C) for up to 28 days.

Manufacturer Information
Soliqua 30 60 is manufactured by Sanofi, a leading global healthcare company dedicated to improving the lives of people worldwide. Sanofi is committed to providing innovative solutions for diabetes management and other health conditions.